Clinical Trial Update: CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of CGB-400 topical gel for rosacea has completed, per the clinical trials registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• CGB-400 Topical Gel

Snippet

Sponsor: CAGE Bio Inc. | Conditions: Rosacea | Phase 2 | Status: COMPLETED